Delivery Method: VIA SIGNATURE CONFIRMED DELIVE Product: Drugs Recipient: Recipient Name Mr. Hong J. Shen Recipient Title Owner Herbal Doctor Remedies 497 Cumbre StreetMonterey Park, CA […]

Delivery Method: VIA UPS Product: Drugs Recipient: Recipient Name Ms. Eleanor Palmer Recipient Title President Coral Pharmaceuticals LTD 20 Longwood Road, P.O. Box F-40729Freeport City, Grand […]

Delivery Method: VIA Parcel Courier Product: Drugs Recipient: Recipient Name Mr. Robert P. Manzo Recipient Title President and Chief Executive Officer The Skin Atelier, Inc. d.b.a. […]

Delivery Method: VIA UPS Reference #: 320-20-03 Product: Drugs Recipient: Recipient Name Mr. Samir Mehta Recipient Title CEO Torrent Pharmaceuticals Limited Torrent HouseOff. Ashram RoadAhmedabad 380009GujaratIndia […]

For Immediate Release: March 21, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, […]

Patient input can help inform the therapeutic context for regulatory review. Patient input also can inform the selection of clinical outcomes, ensure the appropriateness of instruments […]

FDA develops resources – workshops, webinars, and seminars – to help generic drug manufacturers improve the quality of their abbreviated new drug application (ANDA) submissions and […]

Action The U.S. Food and Drug Administration has approved Fabhalta (iptacopan) for the treatment of adults with complement 3 glomerulopathy (C3G) to reduce proteinuria. Fabhalta is […]

Delivery Method: UPS Product: Drugs Recipient: Recipient Name Mr. Il Chong Chung Seindni Co., Ltd. 610-304, 16, Gireum-roSeongbuk-guSeoul02725South Korea Issuing Office: Center for Drug Evaluation and […]